COMMUNIQUÉS West-GlobeNewswire

Nicox : Point d'activité du premier trimestre 2018 et résultats financiers
04/05/2018
Communiqué de presse Nicox : Point d'activité du premier trimestre 2018 et résultats financiers ............................................. 4 mai 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox S.A. (Euronext [...]
Nicox Provides First Quarter 2018 Business and Financial Results
04/05/2018
Press Release Nicox Provides First Quarter 2018 Business and Financial Results .............................................. May 4, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
Bone Therapeutics Business Update for First Quarter 2018
04/05/2018
Regulated information / Press release Bone Therapeutics Business Update for First Quarter 2018 Patient recruitment completed for the Phase IIA lumbar spinal fusion study with ALLOB ® Board strengthened with appointments [...]
Bone Therapeutics publie son rapport d'activité du premier trimestre 2018
04/05/2018
Information réglementée / Communiqué de presse Bone Therapeutics publie son rapport d'activité du premier trimestre 2018 Fin du recrutement dans l'étude de Phase IIA en fusion vertébrale avec ALLOB ® Nomination de Jean [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
04/05/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 4 May 2018, 7am CET - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
04/05/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 4 mai 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]
U.S. FDA Approves Portola Pharmaceuticals’ Andexxa®, First and Only Antidote for the Reversal of Factor Xa Inhibitors
04/05/2018
– Breakthrough Product is a Major Advance in the Treatment of Patients Hospitalized with Life-Threatening Bleeding – – Company to Host Conference Call on Friday, May 4, 2018 at 8:30 a.m. ET – SOUTH SAN FRANCISCO, Calif [...]
Teladoc Prices Upsized Offering of $250 Million of Convertible Senior Notes Due 2025
04/05/2018
PURCHASE, NY, May 03, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) today announced the pricing of its offering of $250 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes”) in a [...]
Compass Cannabis Terminates Proposed Transaction With Isodiol
04/05/2018
CALGARY, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or "the Company") has announced today that, pursuant to the terms of the binding letter agreement dated April 18, [...]
Radient Technologies Inc. Announces Closing of Real Estate Transactions
04/05/2018
EDMONTON, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce it has completed its previously announced real estate acquisitions ( [...]
Terra Tech Corp. Schedules First Quarter 2018 Earnings Release for Thursday, May 10, 2018
03/05/2018
IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]
Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights
03/05/2018
WATERTOWN, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/05/2018
BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to seven new employees for an aggregate of 38,300 shares of common stock [...]
ReWalk Robotics Appoints Yohanan Engelhardt to its Board of Directors and as Chairman of the Audit Committee
03/05/2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 03, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK ) (“ReWalk” or “the Company”) announced today that the Company has appointed Yohanan Engelhardt to the [...]
Adverum Biotechnologies Announces Leadership Changes
03/05/2018
MENLO PARK, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced that [...]
Emergent BioSolutions Reports First Quarter 2018 Financial Results
03/05/2018
Reaffirms full year 2018 financial forecast and operational goals Provides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) reported [...]
The Cooper Companies Announces Release Date for Second Quarter 2018
03/05/2018
PLEASANTON, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release second quarter 2018 financial results on Thursday, June 7, 2018, at 4:15 PM ET. Following the [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
03/05/2018
BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be presenting in three conferences in May. David Roberts, President, is scheduled to present at [...]
Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
03/05/2018
BURLINGAME, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

Pages